VNN2 and neoplasm: While MDSCs are known to inhibit CD8+ T cell proliferation, this study described an inverse association between CD14+ monocytes expressing VNN2 and glioma patient’s tumor grade potentially highlighting a role for VNN2 in less aggressive tumors [49].